Skip to main navigation

Close

Who We Are
- About
- Approach
- Our Team
Dynamo Platform
- Integration of Tools
- Motion-Based Drug Design
Our Science
- Publications
- Pipeline
Patients
Investors & Media
Careers
- Culture & Benefits
- Open Positions

399 Binney Street, 2nd Floor

Cambridge, MA 02139

info@relaytx.com

(617) 370-8837

05

Investors & Media

Press Releases

Overview
News & Events
- Press Releases
- Events
Corporate Presentation
Stock Information
Governance
SEC Filings
Responsibility
Investor Resources

Keyword Search

Year

Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008

May 25, 2023

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

May 24, 2023

Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights

May 4, 2023

Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights

April 27, 2023

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

April 19, 2023

Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations

April 18, 2023

Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR

March 6, 2023

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

March 1, 2023

Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

February 23, 2023

Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

February 16, 2023

Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day

February 2, 2023

Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023

Who We Are
Dynamo Platform
Our Science
Patients
Careers
Contact
Investors & Media
Our Team

Relay Therapeutics

399 Binney Street, 2nd Floor

Cambridge, MA 02139

info@relaytx.com

(617) 370-8837

© Relay Therapeutics 2023

Privacy Policy Terms of Use